coroanrvisu_cdc

Pharmafile.com’s weekly COVID-19 news round-up

pharmafile | August 26, 2020 | News story | Research and Development COVID, COVID-19, coronavirus 

In COVID-19 news this week, China is set to move ahead with human testing of a potential coronavirus vaccine that has been created using insect cells while Australia has signed its first deal to secure doses of a potential vaccine for its citizens, inking a partnership with AstraZeneca and the University of Oxford.

In treatment related news, the FDA could expand its Emergency Use Authorization (EUA) for Gilead’s remdesivir for treating coronavirus patients while AstraZeneca has started a clinical trial of its antibody treatment designed to prevent and also treat symptoms of the virus.

1. AstraZeneca begins antibody COVID-19 treatment trial in the UKPublished on 25/08/20

AstraZeneca has started a clinical trial of its antibody treatment designed to prevent and also treat symptoms of coronavirus.

2. China’s ‘insect’ vaccine for COVID-19 approved for human testingPublished on 24/08/20

China is set to move ahead with human testing of a potential coronavirus vaccine that has been created using insect cells.

3. Gilead says FDA could expand eligibility of coronavirus patients for remdesivirPublished on 24/08/20

The FDA could expand its Emergency Use Authorization (EUA) for Gilead’s remdesivir for treating coronavirus patients, according to Gilead.

4. Australia signs first COVID-19 vaccine deal for 25 million doses of AstraZeneca/Oxford University candidatePublished on 19/08/20

Australia has signed its first deal to secure doses of a potential COVID-19 vaccine for its citizens, inking a partnership with AstraZeneca and the University of Oxford for their jointly developed candidate known as ChAdOx1.

5. UK Government officially announces National Institute for Health Protection to replace Public Health EnglandPublished 19/08/20

The UK Government has officially announced that Public Health England will be replaced by the National Institute for Health Protection.

 

Related Content

FDA approves first oral antiviral to treat adult patients with COVID-19

The US Food and Drug Administration (FDA) has announced that it has approved the oral …

moderna_norwood_plant

Moderna and Pfizer COVID-19 vaccine protection declines over time

Data presented by Pfizer and Moderna ahead of the FDA’s vaccine advisory committee meeting on …

Sanofi complete acquisition of mRNA company Translate Bio

French pharma giants Sanofi continues its run of acquisitions in 2021 by completing the deal …

Latest content